Synthomer Announces Director Share Grant
Why we think this is neutral
The RNS announcement is regarding a director share grant, which is not a mandatory news type that requires detailed analysis. While the grant of shares to the CFO is noteworthy, it does not provide significant new information about the company's financial performance or outlook.
Key Points
- Grant of nil cost options to CFO under Synthomer Performance Share Plan
- Options subject to performance conditions
Summary
The specialty chemicals company has announced a grant of nil cost options to its CFO under the Synthomer Performance Share Plan.
Synthomer plc has announced that its Chief Financial Officer, Lily Liu, has been granted 826,418 nil cost options under the company's Performance Share Plan. The options are subject to performance conditions and were granted on 20 March 2025.
DIRECTOR DEALINGS